You are here

Biocure Technology Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
CURE
CSE Index: 
Currency: 

 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

You are here

Biocure Technology Inc. (CURE)

SEDAR Information

Company Info

Address
300-1055 West Hastings Street
Vancouver, BC V6E 2E9
Canada
Phone
604-609-7146
Fax
N/A
Email
admin@biocuretech.com
Website
http://www.biocuretech.com
Listing date
Monday, May 10, 2010
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Fig House Communications
Email
fighouse@yahoo.com
Auditor
DMCL Chartered Professional Accountants

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
96,793,301
Reserved for Issuance: 

Bulletins

28/11/2017

2017-1117 – Fundamental Change – Gravis Energy Corp./Biocure Technology Inc.

le 28 novembre/November 2017

Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.

Listing and disclosure documents will be available at thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

12_11_13th_MA_Forum_Website

Into the Future – Emerging Tech Conference

Friday, December 14, 2018 -
9:00am to 3:00pm
01_10_New_Year_Kick_Off_2019_Website

New Year Kickoff 2019

Thursday, January 10, 2019 -
6:00pm to 11:00pm
01_20_VRIC_2019_Website

Vancouver Resource Investment Conference - VRIC 2019

Sunday, January 20, 2019 (All day) to Monday, January 21, 2019 (All day)